Who invested in Audentes Therapeutics?
Audentes Therapeutics's investors include OrbiMed, Versant Ventures, 5AM Ventures, Venrock and Deerfield, and 7 more on record.
United States · Series C startup
3 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Audentes Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$138Mraised across 3 rounds since 2013, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $65M sold, first sale Oct 2015
From a historical funding recordSEC filing: $43M sold, first sale Nov 2014
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Audentes Therapeutics's investors include OrbiMed, Versant Ventures, 5AM Ventures, Venrock and Deerfield, and 7 more on record.
Audentes Therapeutics has raised $138M across 3 rounds since 2013.
Audentes Therapeutics's most recent round was a Series C of $65M in Oct 2015.
Its most recent round, $65M in Oct 2015, is also its largest on record.
Audentes Therapeutics's first round on record, in Jul 2013, was backed by OrbiMed, Versant Ventures and 5AM Ventures.
Audentes Therapeutics's latest named round is a Series C, in Oct 2015.
Audentes Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.